Calendar

Financial releases

Date Title  
Toggle Summary AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare Conference
NORTH CHICAGO, Ill. , Feb. 12, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 10 th Annual SVB Leerink Global Healthcare Conference on Friday, February 26 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial
Toggle Summary AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results
- Reports Full-Year Diluted EPS of $2.72 on a GAAP Basis; Adjusted Diluted EPS of $10.56 - Delivers Full-Year Net Revenues of $45.804 Billion on a GAAP Basis, an Increase of 37.7 Percent on a Reported Basis; Adjusted Net Revenues Were $45.784 Billion - Full-Year Global Net Revenues from the
Toggle Summary AbbVie to Host Fourth-Quarter and Full-Year 2020 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 12, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2020 financial results on Wednesday, February 3, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .
Toggle Summary AbbVie to Present at the 39th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Jan. 6, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 39 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 . Members of AbbVie's executive leadership team will present virtually at 3:30 p.m. Central time , including Richard A.
Toggle Summary AbbVie to Host Virtual Immunology Strategic Update
NORTH CHICAGO, Ill. , Dec. 1, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will host a virtual immunology strategic update for investors on Monday, December 14, 2020 at 9:00 a.m. Central time . Richard A. Gonzalez , chairman of the board and chief executive officer, and members of the executive
Toggle Summary AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 24, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Evercore ISI Virtual HealthCONx Conference on Wednesday, December 2 at 1:40 p.m. CT and the Piper Sandler Virtual Healthcare Conference on Thursday, December 3 at 10 a.m. CT .
Toggle Summary AbbVie to Present at the Wolfe Research Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 12, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Thursday, November 19, 2020 . Michael Severino , M.D., vice chairman and president, and Robert A. Michael , executive vice president and chief financial officer,
Toggle Summary AbbVie Reports Third-Quarter 2020 Financial Results
- Reports Third-Quarter Diluted EPS of $1.29 on a GAAP Basis; Adjusted Diluted EPS of $2.83   - Delivers Third-Quarter Net Revenues of $12.902 Billion on a GAAP Basis, an Increase of 52.1 Percent on a Reported Basis; Adjusted Net Revenues Were $12.882 Billion   - Third-Quarter Global Net Revenues
Toggle Summary AbbVie to Host Third-Quarter 2020 Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 6, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2020 financial results on Friday, October 30, 2020 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 11, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.  The cash dividend is payable November 16, 2020 to stockholders of record at the close of business on October 15, 2020 .